Evidence map›Paper›PMID 41357231›Full record

ArticleFrontiers in immunology2025

Mitochondrial damage and IL-1β production in monocytes caused by

Yu Chen, Naomi Shimoda, Coh-Ichi Nihei, Ryuichi Sawa, Yuko Takahashi, Mitsuhiro Nishigori, Shu Nakamura, Jingwei Liu, Takumi Koshiba, Nanako Ushio-Watanabe and 1 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yu ChenNational Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Japan.
Naomi ShimodaNational Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Japan.
Coh-Ichi NiheiInstitute of Microbial Chemistry (BIKAKEN), Tokyo, Japan.
Ryuichi SawaInstitute of Microbial Chemistry (BIKAKEN), Tokyo, Japan.
Yuko TakahashiInstitute of Microbial Chemistry (BIKAKEN), Tokyo, Japan.
Mitsuhiro NishigoriDepartment of Chemistry, Faculty of Science, Fukuoka University, Fukuoka, Japan.
Shu NakamuraNational Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Japan.
Jingwei LiuNational Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Japan.
Takumi KoshibaDepartment of Chemistry, Faculty of Science, Fukuoka University, Fukuoka, Japan.
Nanako Ushio-WatanabeNational Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Japan.
Yoshifumi NishikawaNational Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The intracellular proliferation of Methods: In the infection of human monocytic cell line THP-1 cells with the Results: In the infection of THP-1 cells with the NcGRA7KO parasite, decreased IL-1β release was observed compared with Nc1 infection. Transfection with plasmids for reconstitution of the NLRP3 inflammasome enhanced IL-1b production via additional transfection with NcGRA7 cDNA. NLRP3 inhibitor, CASP1 inhibitor, and NF-κB inhibitor significantly suppressed IL-1β production induced by Nc-1 infection, whereas no inhibitory effect was observed in NcGRA7KO-infected cells. Furthermore, treatment with any of the inhibitors led to a reduction in TNF-α production in both Nc-1- and NcGRA7KO-infected cells. Western blot analysis of phosphorylated NF-κB p65 demonstrated that Discussion: These findings indicate that NcGRA7 does not directly modulate NF-κB activation but likely enhances the production of IL-1β and TNF-α through post-transcriptional mechanisms, thereby contributing to the upregulation of NLRP3 expression. Moreover, our results suggest that NcGRA7 influences both the NF-κB and inflammasome pathways through its interaction with host cell prohibitins. Elucidating the roles of PHB1 and NcGRA7 will provide new insights into the host-parasite interactions underlying

Indexed as

Interleukin-1betaMitochondriaMonocytesNeosporaProtozoan ProteinsRepressor ProteinsHumansInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinProhibitinsTHP-1 CellsTranscription Factor RelATumor Necrosis Factor-alphaIL1B protein, humanInflammasomesInterleukin-1betaNLR Family, Pyrin Domain-Containing 3 ProteinProhibitinsProtozoan ProteinsRepressor ProteinsTranscription Factor RelATumor Necrosis Factor-alphamitochondriamonocyteNcGRA7NLRP3 inflammasomePHB1PHB2

Identifiers

PMID41357231
PMCPMC12675473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.